Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer [Phase 2]
Takeda-sponsored phase 2 trial evaluating niraparib as maintenance therapy in Japanese participants with relapsed ovarian cancer has complet…
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab combined with standard treatment in recurrent platinum-resistant ovarian cancer has completed;…
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial comparing karenitecin to topotecan in advanced epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients [Phase 3]
Phase 3 trial of lurbinectedin (PM01183) in platinum-resistant ovarian cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma [Phase 3]
A Phase 3 trial comparing tri-weekly TJ to weekly TJ in stage II-IV Mullerian carcinoma (epithelial ovarian cancer and related cancers) has …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study [EARLY_Phase 1]
A pilot study evaluating a rapid recovery program in gynecologic oncology surgery has completed early-phase research with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating niraparib in combination with pembrolizumab in triple-negative breast cancer and ovarian cancer has been complete…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer [NA]
A completed clinical trial update on a metastatic tumor cell trap device for advanced ovarian cancer, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Phase Ib Study of Chiauranib in Patients With Ovarian Cancer [Phase 1, Phase 2]
Phase Ib study updates on chiauranib in ovarian cancer; trial phases include Phase 1 and Phase 2 and the study is completed.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating AMG 386 in combination with Paclitaxel for advanced recurrent epithelial ovarian cancer and related…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) [Phase 3]
Phase 3 trial of avelumab in previously untreated epithelial ovarian cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Methods in Education for Breast Cancer Genetics [Phase 3]
A Phase 3 clinical trial update evaluating education methods for genetics in breast cancer and ovarian cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer [Phase 3]
Phase 3 clinical trial assessing reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, and primar…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments [Phase 3]
Phase 3 trial evaluating olaparib in BRCA-mutated relapsed ovarian cancer after platinum-based therapy; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: 3D Versus 2D Laparoscopic Ovarian Cystectomy [NA]
A completed clinical trial comparing 3D versus 2D laparoscopic techniques for ovarian cystectomy; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating adavosertib in combination with chemotherapy for platinum-resistant epithelial ovarian, fallopian tube, or primary …
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) [Phase 3]
Phase 3 trial evaluating avelumab alone or with pegylated liposomal doxorubicin versus doxorubicin alone in platinum-resistant/refractory ov…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing bevacizumab and trabectedin with or without carboplatin in recurrent ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer [Phase 1]
Phase 1b study of paclitaxel with ricolinostat for gynecologic cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer [Phase 2]
Phase 2 trial update evaluating ribociclib plus letrozole in relapsed estrogen receptor-positive cancers of female reproductive tract (ovari…